.

Sunday, July 14, 2013

SEQUENOM Analysis

SEQUENOM AnalysisABOUT SEQUENOMSEQUENOM, Inc., a ancestrals company, provides ancestral depth psychology products that translate genomic knowledge into best solutions for bio checkup research and molecular(a) medicine. The Company has created superior desoxyribonucleic acid abbreviation technology that expeditiously and but measures genetic variation. Sequenom was founded in 1994 and has had remarkable success in its short history. Since its start-up in 1994, Sequenom has ceremonious international operations, launched major products, achieved the import best initial creation offering in the biotechnology industry, and built a stuff metrical foot of top-notch customers. The Companys head activity is to determine the medical impact of genes and genetic variations know as single base polymorphisms. SEQUENOM dedicated to the gross gross and support of the companys MassARRAY chopine, and to the continued working out of DNA analysis applications for implement with this strategy. It has created high- process DNA analysis technology that efficiently and scarce measures genetic variation. Their proprietary MassARRAY system of rules is a high performance DNA analysis platform that efficiently and precisely measures the meat of genetic tar labour material and variations therein. Sequenom has used MassARRAY technology and the companys embrace collections of DNA samples from diseased and wellnessy individuals to pick up disease-related genes that affect the health of substantive portions of the population.
Ordercustompaper.com is a professional essay writing service at which you can buy essays on any topics and disciplines! All custom essays are written by professional writers!
Through high-density genome-wide scans Sequenom has identified more(prenominal) than 60 nominee genes in breast, lung, prostate, and skin cancers; central spooky system dis roves; metabolous and cardiovascular diseases; and musculoskeletal and inflammatory conditions. establish on its disc all overies, Sequenom develops symptomatic content, and besides outlicenses candidate target genes for diagnostic and therapeutic product development. Sequenom employs over 150 people worldwide, with offices in San Diego, Boston, Hamburg, and Brisbane. Since the launch of the MassARRAY system in 2000, Sequenom has sold over ampere-second systems and released a refreshful benchtop discrepancy of the platform, the MassARRAY Compact. BUSINESS MODELSNPs are harsh genetic markers... If you requirement to get a full essay, order it on our website: Ordercustompaper.com

If you want to get a full essay, wisit our page: write my paper

No comments:

Post a Comment